Toremifene clinical trials
Also written Fareston.
How each study uses Toremifene is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Toremifene studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 29 May 1997 · FARESTON · NDA 020497 (FDA, Drugs@FDA)
- European Union
- 14 Feb 1996 · Fareston · EMEA/H/C/000091 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
24 studies that test it; most in 2014 (5)
| Year | Studies |
|---|---|
| 1991 | 1 |
| 1993 | 1 |
| 1999 | 1 |
| 2000 | 1 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2014 | 5 |
| 2017 | 1 |
| 2018 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 16
GTx (4) · Intarcia Therapeutics (4) · Peking Union Medical College Hospital (3) · Satakunta Central Hospital (2) · Shanghai Jiao Tong University School of Medicine (1) · Mayo Clinic (1) · Joel Nelson, MD (1) · Advocate Lutheran General Hospital (1)
Often tested with
Tested in the same studies.
Atamestane (4) · Tamoxifen (4) · Anastrozole (4) · Letrozole (3) · Cyclophosphamide (1) · Doxorubicin (1) · Epirubicin (1) · Goserelin (1)
Related medicines
As reviewed, each with the page that says it.
Studies
Open first, then newest update. How each study uses Toremifene is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 24
- Efficacy of Tamoxifen Versus Toremifene in CYP2D6 IM/PM of Premenopausal Patients With ER-positive Early Breast CancerRecruitingPhase 3Chinese Anti-Cancer AssociationNCT03351062Written as Toremifene
- Prostate Cancer Prevention Study for Men With High Grade PIN (Prostatic Intraepithelial Neoplasia)CompletedPhase 3GTxNCT00106691Written as Toremifene 20 mg
- Selective Estrogen Modulation and Melatonin in Early COVID-19WithdrawnPhase 2Reena Mehra, MDNCT04531748Written as Toremifene
- Safety of Toremifene and Tamoxifen Therapy in Premenopausal Patients With Operable Breast CancerCompletedPhase 4Shanghai Jiao Tong University School of MedicineNCT02344940Written as Toremifene
- Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast CancerWithdrawnPhase 4Fred Hutchinson Cancer CenterNCT03238703Written as Toremifene Citrate
- Toremifene in Treating Patients With Ovarian CancerWithdrawnPhase 2George Washington UniversityNCT00003865Written as toremifene
- Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast CancerStatus unknownPhase 4Peking Union Medical College HospitalNCT02089854Written as Toremifene; Anastrozole
- Estradiol-Receptor Blockade in Older Men and WomenCompletedPhase 1Mayo ClinicNCT02271282Written as Toremifene
- Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast CancerStatus unknownPhase 3Peking Union Medical College HospitalNCT02097459Written as Toremifene
- Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate CancerCompletedPhase 2Joel Nelson, MDNCT00020735Written as toremifene
- Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerCompletedPhase 3Intarcia TherapeuticsNCT00044291Written as toremifene
- Toremifene in Desmoid Tumor: Prospective Clinical Trial and Identification of Potential Molecular TargetsStatus unknownPhase 2Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoNCT02353429Written as Toremifene
- Adjuvant Toremifene With or Without Goserrelin in Premenopausal Women With Stage I-IIIA, Hormonal Receptor Positive Breast Cancer Accompanied With or Without Chemotherapy Induced AmenorrhoeaStatus unknownPhase 3Peking Union Medical College HospitalNCT02132390Written as Toremifene
- Toremifene With or Without Atamestane in Treating Postmenopausal Women With Metastatic Breast CancerTerminatedPhase 3Intarcia TherapeuticsNCT00010322Written as toremifene
- Toremifene Citrate for Prevention of Bone Fractures in Men With Prostate Cancer on Androgen Deprivation TherapyCompletedPhase 3GTxNCT00129142Written as Toremifene Citrate
- A Chemoprevention Study of an Investigational Drug in Men With High Grade Prostate Intraepithelial Neoplasia (PIN)CompletedPhase 2GTxNCT00028353Written as GTX-006 (Acapodene)
- Efficacy and Safety Study of Toremifene Citrate for the Reduction in the Risk of New Bone Fracture Occurrences in Men With Prostate CancerWithdrawnPhase 3GTxNCT01214291Written as Toremifene
- Toremifene in Treating Patients With Desmoid TumorsCompletedPhase 2Advocate Lutheran General HospitalNCT00002595Written as toremifene
- Hormone Therapy and Chemotherapy in Treating Perimenopausal or Postmenopausal Women With Node-Positive Breast CancerCompletedPhase 3ETOP IBCSG Partners FoundationNCT00002529Written as toremifene
- Antiestrogen vs Aromatase Inhibitor After Adjuvant Chemotherapy for Breast CancerTerminatedPhase 2Japan Breast Cancer Research NetworkNCT00437359Written as Toremifene citrate
See all 24 studies that test Toremifene →
Given beside what is tested · 2 — Toremifene is usual care or a partner of the new treatment
- Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)RecruitingPhase 3Fudan UniversityNCT05891093Written as Toremifene
- Neoadjuvant Toremifene With Melatonin or Metformin in Locally Advanced Breast CancerStatus unknownPhase 2N.N. Petrov National Medical Research Center of OncologyNCT02506790Written as Toremifene
As the comparator · 1 — what is tested is compared with Toremifene
Codes
What other systems call Toremifene · ClinicalTrials.gg INT008580
- MeSH (NLM) D017312ToremifeneConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 7NFE54O27TTOREMIFENEConfirmed FDA, NLM, Wikidata
- RxNorm 38409Confirmed FDA, Wikidata
- Wikidata Q3993743(Z)-ToremifeneConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C1256ToremifeneOne source FDA
- DrugBank DB00539One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D017312 | Toremifene | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 7NFE54O27T | TOREMIFENE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 38409 | — | Confirmed FDA, Wikidata |
| Wikidata | Q3993743 | (Z)-Toremifene | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C1256 | Toremifene | One source FDA |
| DrugBank | DB00539 | — | One source Wikidata |
Also registered as toremifene citrate (UNII 2498Y783QT · RxNorm 49953).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.